TechnologyProstate cancer
OICR NEWS
OICR News
OICR accelerates cancer research to produce better health in the province. We do this by supporting talent, technology, commercialization and collaboration.
Latest
Technology·Breast cancer
Early signs of cancer detected in blood up to eight years before diagnosis
Article·
Technology·Prevention
Why chemotherapy harms your bone marrow and how the damage could be prevented
Article·
Featured
Technology
OICR Investigator Dr. Antastasia Tikhonova led an important discovery about what happens to the bone marrow during a well-known precancerous condition. A first-ever discovery about how bone marrow changes in people at a higher risk…
Article·
More stories
Discover more stories
Talent·Prevention
New OICR Investigator discusses coming home to Ontario, the link between antioxidants and cancer, and how he wants his research to help improve your diet. Dr. Isaac Harris was recently recruited to McMaster University and…
Article·
Talent
Dr. Aaron Schimmer joined OICR as its new President and Scientific Director in August, and as the clinician-scientist settles into his new role, he sat down with OICR News for a chat about why he…
Article·
Collaboration·All cancers
OICR’s Dr. Lincoln Stein and Dr. Mélanie Courtot were part of an expert international commission to understand and overcome challenges in precision oncology. The results of a global commission on equity in precision oncology were…
Article·
Cancer solved together — in your inbox
The latest findings, funding, and partnerships from Ontario’s cancer research institute. Briefings and deeper dives.
Subscribe
Technology·Prostate cancer
Exciting new findings from a landmark international collaboration co-led by OICR were published in Nature. Prostate cancer leaves behind genetic “fingerprints” that provide clues about how aggressive it will become and could help personalize cancer…
Article·
Technology·Ovarian cancer
Support from OICR is helping increase uptake in an ovarian tissue cryopreservation program, which is offered to young cancer patients whose treatment might affect their fertility in the future. The weeks after Evelyn Pijper was…
Article·
Commercialization
The WeSEED program from FACIT and OBIO® provides support and seed investment for women-led life sciences companies. Two of Ontario’s leading drivers of life sciences innovation have teamed up to empower the province’s women entrepreneurs,…
Article·